Neogen names Donofrio VP of Food Safety R&D

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., April 19, 2018 — Neogen Corporation (NASDAQ: NEOG) announced today that it had named Dr. Robert Donofrio as Vice President of Food Safety Research and Development. Donofrio had recently served as the director of this group of 75 scientists. “Neogen’s Board of Directors is pleased to... Read more

Twist Bioscience Accelerates Global Expansion with Strategic Asia Pacific Distribution Agreements

Download PDF SAN FRANCISCO, Calif.  – April 18, 2018 — Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that the company has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the... Read more

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

Cambridge, MA – April 18, 2018 ReviveMed Inc., today announced it has closed an oversubscribed seed round of $1.5 million to advance its artificial intelligence (AI)-driven platform that unlocks the value of metabolomics data for drug discovery and development. Rivas Capital led the round, which also included participation from several institutional investors including TechU, Team... Read more

Grand Opening of UC Irvine Materials Research Institute (IMRI) to Spotlight JEOL Center for Nanoscale Solutions

GRAND ARM Transmission Electron Microscope – JEOL Center for Nanoscale Solutions at California Irvine Materials Research Institute (IMRI) April 18, 2017 – Peabody, Mass. —- World-renowned electron microscopists will join Dr. Xiaoqing Pan, Director of the University of California Irvine Materials Research Institute (IMRI), for the Grand Opening of the JEOL Center for Nanoscale Solutions and... Read more

Swift Biosciences Launches Accel-Amplicon™ Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon... Read more

MilliporeSigma Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Award recognizes new, fully synthetic clarification filter Millistak+® HC Pro portfolio of depth filters improves capacity, reducing footprint by up to 2x for primary clarification Burlington, Massachusetts, April 18, 2018 — MilliporeSigma today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation. “MilliporeSigma is dedicated to delivering innovations that bring... Read more

Seegene Will Unveil Combination Test at ECCMID 2018

SEOUL, South Korea, April 17, 2018 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, announced that it will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases (“ECCMID 2018”) taking place in Madrid, Spain, from April 21 to 24, 2018, where it will introduce the “combination test,” which is a high-efficiency solution that diagnoses... Read more

Labcyte Reaches Agreement With Merck to Supply Acoustic-Mass Spectrometry Equipment

April 17, 2018 04:30 AM Pacific Daylight Time SAN JOSE, Calif.–(BUSINESS WIRE)–Labcyte Inc. announced today that the company has entered an agreement with Merck, known as MSD outside the United States and Canada, to utilize Acoustic-Mass Spectrometry (Acoustic-MS) in drug discovery and development. Pioneered by Labcyte, acoustic droplet ejection (ADE) technology uses the gentle energy... Read more

RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy

SEATTLE, April 16, 2018 /PRNewswire/ — RareCyte, Inc., a global rare cell detection and liquid biopsy company, announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest member of the CyteFinder family, enables high-speed whole slide imaging with up to six channels... Read more